Oxidative stress and quality of life in elderly patients with obstructive sleep apnea syndrome: Are there differences after six months of Continuous Positive Airway Pressure treatment?

Clinics

Volumn 67, Issue 6, 2012, Pages 565-571

  Yagihara, Fabiana ^a   Lucchesi, Ligia Mendonça ^a   D'Almeida, Vãnia ^a   de Mello, Marco Túlio ^a   Tufik, Sergio ^a   Bittencourt, Lia Rita Azeredo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Continuous Positive Airway Pressure; Elderly; Obstructive sleep apnea syndrome; Oxidative stress; Quality of life

Indexed keywords

AGED; ARTICLE; BLOOD; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; SLEEP DISORDERED BREATHING; TIME; TREATMENT OUTCOME;

AGED; CONTINUOUS POSITIVE AIRWAY PRESSURE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; QUALITY OF LIFE; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866341952     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(06)04     Document Type: Article

References (51)

1. American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22(5):667-89.
2. Hirata RP, Aguiar IC, Nacif SR, Giannasi LC, Leitao FS Filho, Santos IR, et al. Observational study on efficacy of negative expiratory pressure test proposed as screening for obstructive sleep apnea syndrome among commercial interstate bus drivers-protocol study. BMC Pulm Med. 2011;11:57, http://dx.doi.org/10.1186/1471-2466-11-57.
3. Romano S, Salvaggio A, Lo Bue A, Marrone O, Insalaco G. A negative expiratory pressure test during wakefulness for evaluating the risk of obstructive sleep apnea in patients referred for sleep studies. Clinics. 2011;66(11):1887-94, http://dx.doi.org/10.1590/S1807-59322011001100007.
4. Patil SP, Schneider H, Schwartz AR, Smith PL. Adult obstructive sleep apnea-Pathophysiology and diagnosis. Chest. 2007;132(1):325-37, http://dx.doi.org/10.1378/chest.07-0040.
5. Owens RL, Eckert DJ, Yeh SY, Malhotra A. Upper airway function in the pathogenesis of obstructive sleep apnea: a review of the current literature. Curr Opin Pulm Med. 2008;14(6):519-24, http://dx.doi.org/10.1097/MCP.0b013e3283130f66.
6. Romano S, Salvaggio A, Hirata RP, Lo Bue A, Picciolo S, Oliveira LV, et al. Upper airway collapsibility evaluated by a negative expiratory pressure test in severe obstructive sleep apnea. Clinics. 2011;66(4):567-72, http://dx.doi.org/10.1590/S1807-59322011000400008.
7. Cahali MB, Soares CF, Dantas DA, Formigoni GG. Tonsil volume, tonsil grade and obstructive sleep apnea: is there any meaningful correlation? Clinics. 2011;66(8):1347-52, http://dx.doi.org/10.1590/S1807-59322011000800007.
8. Young T. Sleep-disordered breathing in older adults: Is it a condition distinct from that in middle-aged adults? Sleep. 1996;19(7):529-30.
9. Tishler PV, Larkin EK, Schluchter MD, Redline S. Incidence of sleepdisordered breathing in an urban adult population-The relative importance of risk factors in the development of sleep-disordered breathing. JAMA. 2003;289(17):2230-7, http://dx.doi.org/10.1001/jama.289.17.2230.
10. Pizza F, Contardi S, Mondini S, Trentin L, Cirignotta F. Daytime sleepiness and driving performance in patients with obstructive sleep apnea: comparison of the MSLT, the MWT, and a simulated driving task. Sleep. 2009;32(3):382-91.
11. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009;373(9657):82-93, http://dx.doi.org/10.1016/S0140-6736(08)61622-0.
12. Hattori M, Kitajima T, Mekata T, Kanamori A, Imamura M, Sakakibara H, et al. Risk factors for obstructive sleep apnea syndrome screening in mood disorder patients. Psychiatry Clin Neurosci. 2009;63(3):385-91, http://dx.doi.org/10.1111/j.1440-1819.2009.01956.x.
13. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165(5):677-82.
14. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84, http://dx.doi.org/10.1016/j.biocel.2006.07.001.
15. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. Chronic intermittent hypoxia activates nuclear factor-kappa B in cardiovascular tissues in vivo. Biochem Biophys Res Commun. 2006;343(2):591-6, http://dx.doi.org/10.1016/j.bbrc.2006.03.015.
16. Baldwin CM, Bootzin RR, Schwenke DC, Quan SF. Antioxidant nutrient intake and supplements as potential moderators of cognitive decline and cardiovascular disease in obstructive sleep apnea. Sleep Med Rev. 2005;9(6):459-76, http://dx.doi.org/10.1016/j.smrv.2005.04.004.
17. Tokuda F, Sando Y, Matsui H, Yokoyama T. N epsilon-(hexanoyl) lysine, a new oxidative stress marker, is increased in metabolic syndrome, but not in obstructive sleep apnea. Am J Med Sci. 2009;338(2):127-33.
18. Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. ILAR J. 2009;50(3):289-306.
19. Bonsignore MR, Zito A. Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk. Arch Physiol Biochem. 2008;114(4):255-60, http://dx.doi.org/10.1080/13813450802307451.
20. Celec P, Hodosy P, Behuliak M, Pálffy R, Gardlík M, Halčák L, et al. Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath. 2012;16(2):393-8, http://dx.doi.org/10.1007/s11325-011-0510-4
21. Lavie L. Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis. 2009;51(4):303-12, http://dx.doi.org/10.1016/j.pcad.2008.08.003.
22. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159(2):461-7.
23. Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med. 2009;10(1):87-94, http://dx.doi.org/10.1016/j.sleep.2007.10.011.
24. Sharma SK, Agrawal S, Damodaran D, Sreenivas V, Kadhiravan T, Lakshmy R, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011;365(24):2277-86.
25. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008;134(4):686-92, http://dx.doi.org/10.1378/chest.08-0556.
26. Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, et al. Sleep Heart Health Study Research Group. Predictors of sleepdisordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med. 2002;162(8):863-900.
27. Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med. 2010;11(5):441-6, http://dx.doi.org/10.1016/j.sleep.2009.10.005.
28. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;7(6):e1000132, http://dx.doi.org/10.1371/journal.pmed.1000132.
29. Lavie P, Lavie L. Cardiovascular morbidity and mortality in obstructive sleep apnea. Curr Pharm Des. 2008;14(32):3466-73, http://dx.doi.org/10.2174/138161208786549317.
30. Pavlova MK, Duffy JF, Shea SA. Polysomnographic respiratory abnormalities in asymptomatic individuals. Sleep. 2008;31(2):241-8.
31. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea-A population health perspective. Am J Resp Crit Care. 2002;165(9):1217-39, http://dx.doi.org/10.1164/rccm.2109080.
32. Câmara dos Deputados C. Estatuto do idoso. In: Senado Federal, Secretaria Especial de Editoração e Publicações: Câmara dos Deputados, Centro de Documentação e Informaçã o, Coordenação de Publicações; 2003.
33. Organização Pan-Americana da Saú de. Envelhecimento ativo: uma política de saú de. Brasília: OPAS; 2005.
34. International Classification of Sleep Disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy Of Sleep Medicine; 2005.
35. Bittencourt LRA, Silva RS, Conway SG. Laborató rio do sono-Estrutura física e pessoal, técnica polissonográfica, questionário de sono e banco de dados. São Paulo: Associação Fundo de Incentivo a Psicofarmacologia-AFIP. 2005.
36. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-5.
37. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247-63.
38. Rechtschaffen A, Kales A. A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute. 1968.
39. Bonnet M, Carley D, Carskadon M, Easton P, Guilleminault C, Harper R, et al. EEG Arousals: Scoring Rules And Examples: A Preliminary Report From The Sleep Disorders Atlas Task Force Of The American Sleep Disorders Association. Sleep. 1992;15(2):173-84.
40. Chesson AL Jr, Wise M, Davila D, Johnson S, Littner M, Anderson WM, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 1999;22(20):961-9.
41. Brandão LC, Hachul H, Bittencourt LR, Baracat EC, Tufik S, D'Almeida V. Effects of isoflavone on oxidative stress parameters and homocysteine in postmenopausal women complaining of insomnia. Biol Res. 2009;42(3):281-7.
42. Teramoto S, Yamaguchi Y, Yamamoto H, Hanaoka Y, Ishii M, Shinichiro H, et al. Increase in oxidative stress levels in elderly patients with obstructive sleep apnea syndrome: Effects of age and sex. J Am Geriatr Soc. 2008;56(3):569-71, http://dx.doi.org/10.1111/j.1532-5415.2008.01577.x.
43. Guemouri L, Artur Y, Herbeth B, Jeandel C, Cuny G, Siest G. Biological Variability of Superoxide-Dismutase, Glutathione-Peroxidase, and Catalase in Blood. Clin Chem. 1991;37(11):1932-7.
44. Barceló A, Barbé F, de la Peña M, Vila M, Pérez G, Piérola J, et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J. 2006;27(4):756-60, http://dx.doi.org/10.1183/09031936.06.00067605.
45. Jing J, Huang T, Cui W, Shen H. Effect on quality of life of continuous positive airway pressure in patients with obstructive sleep apnea syndrome: a meta-analysis. Lung. 2008;186(3):131-44, http://dx.doi.org/10.1007/s00408-008-9079-5.
46. Martinez-Garcia MA, Soler-Cataluna JJ, Roman-Sanchez P, Gonzalez V, Amoros C, Montserrat JM. Obstructive sleep apnea has little impact on quality of life in the elderly. Sleep Med. 2009;10(1):104-11, http://dx.doi.org/10.1016/j.sleep.2007.11.009.
47. One SH, Onen F, Albrand G, Decullier E, Chapuis F, Dubray C. Pain tolerance and obstructive sleep apnea in the elderly. J Am Med Dir Assoc. 2010;11(9):612-6, http://dx.doi.org/10.1016/j.jamda.2010.04.003.
48. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleepapnea. Eur Respir J. 1995;8(7):1161-78, http://dx.doi.org/10.1183/09031936.95.08071161.
49. Bittencourt LR, Silva RS, Santos RF, Pires ML, Mello MT. Excessive daytime sleepiness. Rev Bras Psiquiatr. 2005;27(Suppl 1):16-21, http://dx.doi.org/10.1590/S1516-44462005000500004.
50. Lurie A. Endothelial dysfunction in adults with obstructive sleep apnea. Adv Cardiol. 2011;46:139-70, http://dx.doi.org/10.1159/000325108.
51. Lurie A. Inflammation, oxidative stress, and procoagulant and thrombotic activity in adults with obstructive sleep apnea. Adv Cardiol. 2011;46:43-66, http://dx.doi.org/10.1159/000325105.